Epsilon M&A Deal Report - Dialogue (now Amplifon Belgium NV)

Transaction Multiples for the Valuation of Private Companies

Amplifon > Dialogue (now Amplifon Belgium NV)

Announced Date : 08 July 2009

Type : Acquisition of Majority Stake

Deal Value : Yes

Acquirer : Amplifon

Target: Dialogue (now Amplifon Belgium NV)

Target Country: Belgium

Sector of activity : Health, Pharmaceuticals & Biotechnology

Business Description :

> Dialogue is the second largest distributor of hearing-aids in Belgium, with a market share ...

No EMAT : 20303

Transaction multiples available

	EV/Sales	EV/Gross Profit	EV/EBITDA	EV/EBIT	Eq/PBT	P/E	Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating *

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1245

Example of comparable transactions on EMAT (same sub-sector):

Date	Acquirer	Target	Country	Multiples	See details
08/12/2008	Group of French pharmacies and hospitals	Laboratoires Pharmaceutiques Dexo SA	France	**
04/08/2009	Zeria Pharmaceutical Co	Tillotts Pharma	Switzerland	*

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Subscribe to EMAT database